| Ticker Symbol: | CPTS |
|---|---|
| Exchange: | NASD |
| Contact Info: | 331 East Evelyn Mountain CA 94041 650 962-4000 |
| CEO/President: | Mark M. Sieczkarek |
| Industry: | Medical Products / Standard Industry Code: 3841 |
| Description: | Conceptus, Inc. designs and develops minimally invasive devices for reproductive medical applications. Conceptus\' focus is to develop its STOP non-surgical permanent contraception device for women. STOP is designed to be a less-invasive, safer, and less costly alternative to surgical sterilization, more commonly known as tubal ligation. The STOP device is designed to achieve contraception by elliciting a tissue response which occludes the fallopian tubes. |
| Shares Outstanding: | 30,350 (000) | Market Value: | 423,730 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 97.75% | Number of Inst.Shareholders: | 6.91% |
| Last Quarter Sales: | 26.65 ($Mil.) | Last Quarter Net Income: | 2.97 ($Mil.) |
| Last Quarter EPS: | 0.10 | P/E Ratio: | 0 |
| Most Recent Earnings: | 0.10 on 10/29/08 | Earnings Per Share: | -0.25 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| BOSTON SCIENTIF | -37.20 | 7.39 | |
| MEDTRONIC INC | -27.50 | 37.45 | |
| BAXTER INTL INC | +0.00 | 60.00 | |
| ZIMMER HOLDINGS | -44.20 | 42.00 | |
| ST. JUDE MEDICA | -21.40 | 32.92 |
